HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sheetal Sharma Selected Research

Carbenoxolone

1/2021Neuroprotective effects of carbenoxolone against amyloid-beta 1-42 oligomer-induced neuroinflammation and cognitive decline in rats.
1/2020Maintenance of Amyloid-beta Homeostasis by Carbenoxolone Post Aβ-42 Oligomer Injection in Rat Brain.
4/2019Carbenoxolone Reverses the Amyloid Beta 1-42 Oligomer-Induced Oxidative Damage and Anxiety-Related Behavior in Rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sheetal Sharma Research Topics

Disease

6Neoplasms (Cancer)
01/2021 - 09/2010
5Body Weight (Weight, Body)
08/2021 - 04/2019
5Alzheimer Disease (Alzheimer's Disease)
02/2020 - 09/2016
3Infections
04/2021 - 05/2011
2Inflammation (Inflammations)
12/2021 - 06/2017
2Cognitive Dysfunction
01/2021 - 04/2019
1COVID-19
03/2022
1Varicose Veins (Varicose Vein)
06/2021
1Pyogenic Granuloma
06/2021
1Oral Leukoplakia
04/2021
1Erythema
04/2021
1Memory Disorders (Memory Loss)
01/2021
1Neuroinflammatory Diseases
01/2021
1Cardiotoxicity
01/2020
1Ischemia
12/2019
1Stroke (Strokes)
10/2019
1Hemorrhage
10/2019
1Myocardial Infarction
10/2019
1Thrombosis (Thrombus)
10/2019
1Neurodegenerative Diseases (Neurodegenerative Disease)
06/2017
1Chronic Obstructive Pulmonary Disease (COPD)
01/2017
1Amyloid Plaque
09/2016
1Hepatitis E
07/2016
1Vitamin D Deficiency
04/2016
1Foot-and-Mouth Disease
12/2014
1Sepsis (Septicemia)
05/2011

Drug/Important Bio-Agent (IBA)

5Amyloid beta-PeptidesIBA
01/2021 - 09/2016
4Peptides (Polypeptides)IBA
03/2022 - 09/2016
4Proteins (Proteins, Gene)FDA Link
02/2020 - 01/2017
3CarbenoxoloneIBA
01/2021 - 04/2019
3DNA (Deoxyribonucleic Acid)IBA
06/2013 - 09/2010
2LipopolysaccharidesIBA
12/2021 - 06/2017
2CurcuminIBA
12/2021 - 06/2017
2Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2021 - 12/2019
2CytokinesIBA
01/2021 - 12/2019
1ManganeseIBA
08/2021
1Sclerosing Solutions (Sclerosing Agents)IBA
06/2021
1Polidocanol (Laureth)FDA Link
06/2021
1Fluconazole (Zonal)FDA LinkGeneric
04/2021
1Virulence Factors (Pathogenicity Factors)IBA
04/2021
1Neuroprotective AgentsIBA
01/2021
1Lactic Acid (Lactate)FDA LinkGeneric
02/2020
1venetoclaxIBA
01/2020
1ibrutinibIBA
01/2020
1Molecular Chaperones (Chaperone, Molecular)IBA
01/2020
1Heat-Shock Proteins (Heat-Shock Protein)IBA
01/2020
1Hematoxylin (Haematoxylon)IBA
12/2019
1Eosine Yellowish-(YS) (Eosin)IBA
12/2019
1Neurotransmitter Agents (Neurotransmitter)IBA
12/2019
1Tissue Plasminogen Activator (Alteplase)FDA Link
10/2019
1StreptokinaseFDA Link
10/2019
1FibrinIBA
10/2019
1Anti-Anxiety Agents (Anxiolytics)IBA
04/2019
1Amyloid (Amyloid Fibrils)IBA
09/2017
1Bronchodilator Agents (Bronchodilators)IBA
01/2017
1thioflavin TIBA
09/2016
1Glutathione (Reduced Glutathione)IBA
07/2016
1Phosphorus (Red Phosphorus)IBA
04/2016
1CalciumIBA
04/2016
1Alkaline PhosphataseIBA
04/2016
15' Untranslated Regions (5' UTR)IBA
12/2014
1Intercalating AgentsIBA
06/2013
11,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA
12/2012
1Ligases (Synthetase)IBA
12/2012
1Pharmaceutical PreparationsIBA
05/2011
1Anti-Bacterial Agents (Antibiotics)IBA
05/2011

Therapy/Procedure

3Therapeutics
03/2022 - 01/2017
1Sclerotherapy
06/2021
1Immunotherapy
01/2021
1Drug Therapy (Chemotherapy)
01/2017